The comparison desk
Which question reached the instrument?
The comparison starts with a question, then looks for the study that actually asked it.
Identity, duration, location and risk
The seized-sample paper identified CJC-1295. The hormone studies measured its prolonged biological response. Those are distinct accomplishments even when the peptide name stays the same. Comparing questions gives me firmer footing than a single ranking of compounds.
| Question | Material or population | Measurement and result |
|---|---|---|
| What was in the sample? | An unknown seized preparation | LC-MS/MS identified CJC-1295. The answer concerned that preparation. |
| How long did the response last? | Healthy adults given long-acting CJC-1295 | Repeated blood tests found prolonged GH and IGF-1 elevations. |
| Where did fat change? | Adults with HIV and abdominal fat accumulation | Tesamorelin changed visceral fat and liver-fat measurements versus placebo. |
| Did a blood level travel with risk? | People receiving chronic hemodialysis | Circulating MOTS-c was associated with mortality and cardiovascular events. |
| Could the receptor signals reinforce each other? | Engineered cells | Dual-receptor activation produced a larger cAMP response. The fixed blend still lacks a human trial. |
The CJC-1295, tesamorelin, MOTS-c and CJC-1295 / Ipamorelin pages follow those questions in detail.
Next measurements
For CJC-1295, I’m interested in health outcomes over a period long enough to assess the consequences of sustained hormone exposure. The preserved pulses and raised trough are a substantial pharmacology result; the clinical value remains unsettled.
For tesamorelin, the return of visceral fat after discontinuation makes duration and long-term safety especially consequential. Its approved use and strongest trial evidence concern HIV-associated lipodystrophy. A claim about another population needs a trial in that population.
For MOTS-c, the immediate gap is human evidence on an administered peptide: how it behaves, whether it helps, and what harm occurs. The dialysis cohort measured a naturally occurring blood level. For the combination, the missing object is simpler to name: the actual fixed pair, studied against appropriate comparison groups.
I’m happy for these questions to remain different. Turning them into a single score would lose the most interesting information the experiments have already supplied.